Industry Focus
Healthcare: What's Up With Mylan's EpiPen Pricing?
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:28:13
- Mas informaciones
Informações:
Sinopsis
An EpiPen pricing debacle, an unexpected FDA rejection, and a sticker-shock inspiring M&A deal led to wild moves in Mylan N.V., Portola Pharmaceuticals, and Medivation this week.
